1. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
   Eleonora A. Braga et al, 2020, International Journal of Molecular Sciences CrossRef
2. Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma
   Teng Deng et al, 2021, Frontiers in Oncology CrossRef
3. Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
   Zhijing Na et al, 2021, Frontiers in Genetics CrossRef
4. The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
   Martín Salamini-Montemurri et al, 2020, Cancers CrossRef
5. Integrated Bioinformatics Analysis of DNA Methylation Biomarkers in Thyroid Cancer Based on TCGA Database
   Lifeng Zhao et al, 2022, Biochemical Genetics CrossRef
6. CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
   Yonglin Yi et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
7. The Role of microRNAs in Epithelial Ovarian Cancer Metastasis
   Vu Hong Loan Nguyen et al, 2020, International Journal of Molecular Sciences CrossRef
8. LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
   Zining Li et al, 2022, Frontiers in Pharmacology CrossRef
9. Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer
   Shanshan Luo et al, 2021, Scientific Reports CrossRef
10. Long Non-Coding RNA MEG3 in Cellular Stemness
    Pei-Fang Hsieh et al, 2021, International Journal of Molecular Sciences CrossRef
11. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2‐AS2/MEK/ERK/STAT3 signaling
    Lele Ling et al, 2024, The Journal of Gene Medicine CrossRef
12. Predict lncRNA-drug associations based on graph neural network
    Peng Xu et al, 2024, Frontiers in Genetics CrossRef
13. Deciphering the Long Non-Coding RNAs and MicroRNAs Coregulation Networks in Ovarian Cancer Development: An Overview
    César López-Camarillo et al, 2021, Cells CrossRef
14. Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis
    Julia Teppan et al, 2020, Non-Coding RNA CrossRef
15. Anisomycin inhibits angiogenesis, growth, and survival of triple-negative breast cancer through mitochondrial dysfunction, AMPK activation, and mTOR inhibition
    Wenjuan Yang et al, 2022, Canadian Journal of Physiology and Pharmacology CrossRef
16. Mechanisms associated with cuproptosis and implications for ovarian cancer
    Biqing Chen et al, 2024, Journal of Inorganic Biochemistry CrossRef
17. Metabolic perturbation of Streptomyces albulus by introducing NADP-dependent glyceraldehyde 3-phosphate dehydrogenase
    Jiaqi Mao et al, 2024, Frontiers in Microbiology CrossRef
18. Decoding the Oncogenic Signals from the Long Non-Coding RNAs
    Revathy Nadhan et al, 2021, Onco CrossRef
19. The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications
    Zhong Hu et al, 2024, Frontiers in Oncology CrossRef
20. The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers
    Faiza Naz et al, 2021, Cancers CrossRef